Published in World J Surg on September 01, 2010
Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine (Baltimore) (2015) 1.88
Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One (2013) 1.63
Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget (2015) 0.99
Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients. World J Surg (2015) 0.87
Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. World J Gastroenterol (2012) 0.86
Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization-A Meta-Analysis. Gastroenterol Res Pract (2015) 0.85
Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Drug Des Devel Ther (2015) 0.80
Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival. Dig Dis Sci (2011) 0.79
Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization. Radiat Oncol (2014) 0.77
Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget (2016) 0.77
Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation. Medicine (Baltimore) (2015) 0.77
Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma. BMC Surg (2016) 0.76
Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World J Surg Oncol (2016) 0.76
Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clin (2016) 0.76
Clinical implications of basic research in hepatocellular carcinoma. J Hepatol (2015) 0.76
Liver resection for intermediate hepatocellular carcinoma. World J Hepatol (2016) 0.75
Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma. Drug Des Devel Ther (2015) 0.75
Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma. Exp Ther Med (2016) 0.75
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine (Baltimore) (2017) 0.75
Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study. Oncotarget (2016) 0.75
Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria. World J Surg (2012) 0.75
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet (2002) 12.16
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology (2003) 11.55
EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol (2008) 9.14
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology (2002) 4.83
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 4.73
V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Ann Surg (1908) 4.70
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology (2005) 3.95
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology (1998) 3.62
Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet (1985) 3.42
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology (2005) 3.26
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Chemoembolization for hepatocellular carcinoma. Gastroenterology (2004) 2.89
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut (2002) 1.66
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53
Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg (2002) 1.23
Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology (1998) 1.14
Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol (2000) 1.03
Hepatic resection for large hepatocellular carcinoma. Am J Surg (2001) 1.01
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm. Hepatogastroenterology (2002) 0.91
Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection. Eur J Surg Oncol (2005) 0.90
Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology (1999) 0.90
Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg (1994) 0.90
Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg (1998) 0.90
Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol (2003) 0.89
Donor difficulties in Japan and Asian countries. Transplant Proc (1995) 0.84
Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma. Semin Oncol (1997) 0.79
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst (2009) 2.88
Clinical entity and treatment strategies for adult intussusceptions: 20 years' experience. Dis Colon Rectum (2007) 2.76
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Value of CT in the diagnosis and management of gallstone ileus. World J Gastroenterol (2005) 2.31
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep (2012) 2.20
Carbon dioxide insufflation does not reduce pain scores during colonoscope insertion in unsedated patients: a randomized, controlled trial. Gastrointest Endosc (2013) 2.06
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Cystic lymphangioma of the jejunal mesentery in an adult: a case report. World J Gastroenterol (2005) 1.76
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir. J Gastroenterol Hepatol (2013) 1.64
Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg (2008) 1.63
Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet (2009) 1.58
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Does previous abdominal surgery increase postoperative complication rates in continuous ambulatory peritoneal dialysis? Perit Dial Int (2007) 1.53
A prospective trial of variable stiffness colonoscopes with different tip diameters in unsedated patients. Am J Gastroenterol (2008) 1.50
Pyogenic liver abscess treated by percutaneous catheter drainage: MDCT measurement for treatment outcome. Eur J Radiol (2011) 1.50
Spontaneous chylous peritonitis mimicking acute appendicitis: a case report and review of literature. World J Gastroenterol (2006) 1.49
Unusual presentation of cystic liver metastases from nasopharyngeal carcinoma. Onkologie (2008) 1.46
Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer. Onkologie (2010) 1.44
Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci U S A (2008) 1.43
A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach. J Surg Oncol (2008) 1.43
Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma. J Gastroenterol Hepatol (2013) 1.43
Small-bowel perforation caused by fish bone. World J Gastroenterol (2005) 1.42
Percutaneous transgastric traction-assisted esophageal endoscopic submucosal dissection: a randomized controlled trial in a porcine model. Scand J Gastroenterol (2012) 1.41
Isolated tuberculous liver abscesses with multiple hyperechoic masses on ultrasound: a case report and review of the literature. Liver Int (2003) 1.39
Midgut volvulus in an adult with congenital malrotation. Am J Surg (2008) 1.38
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38
Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol (2006) 1.37
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat (2012) 1.37
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis (2008) 1.34
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomarkers Prev (2007) 1.34
Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A (2008) 1.33
Acute myelogenous leukemia and acute leukemic appendicitis: a case report. World J Gastroenterol (2009) 1.33
Intrauterine contraceptive device appendicitis: a case report. World J Gastroenterol (2005) 1.33
Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer (2007) 1.31
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer (2005) 1.25
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res (2003) 1.21
Vascularized lymph node transfer based on the hilar perforators improves the outcome in upper limb lymphedema. Ann Plast Surg (2011) 1.20
The effectiveness of benzydamine hydrochloride spraying on the endotracheal tube cuff or oral mucosa for postoperative sore throat. Anesth Analg (2010) 1.19
Ectopic pancreas presenting as ampulla of Vater tumor. Am J Surg (2008) 1.14
Bilateral superficial cervical plexus block combined with general anesthesia administered in thyroid operations. World J Surg (2010) 1.14
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis (2006) 1.12
Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int J Cancer (2005) 1.12
Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res (2004) 1.11
Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid (2008) 1.11
Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Cancer (2006) 1.11
Endoscopic submucosal dissection with the pulley method for early-stage gastric cancer (with video). Gastrointest Endosc (2010) 1.11
Endoscopic submucosal dissection with internal traction for early gastric cancer (with video). Gastrointest Endosc (2007) 1.09
Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol (2003) 1.09
SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Int J Cancer (2007) 1.06
Management of spontaneously ruptured hepatocellular carcinoma and hemoperitoneum manifested as acute abdomen in the emergency room. World J Surg (2012) 1.06
Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands. Ann Surg Oncol (2008) 1.05
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study. J Hepatol (2012) 1.05
High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Genes Chromosomes Cancer (2004) 1.04
Diverticulosis of the jejunum with intestinal obstruction: A case report. World J Gastroenterol (2005) 1.04
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol Appl Pharmacol (2009) 1.03
Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat (2010) 1.02
Is this a lipoma? Am J Med (2008) 1.02
Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review. Onkologie (2012) 1.02
Endoscopic submucosal dissection for early colorectal neoplasms: clinical experience in a tertiary medical center in taiwan. Gastroenterol Res Pract (2013) 1.01
Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res (2003) 1.01
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci U S A (2013) 1.00
Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev (2007) 1.00
Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava: surgery or not? Dig Dis Sci (2007) 0.99
Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. Eur J Radiol (2011) 0.99